Group items tagged

We invite you to join our complimentary 1-hour Pain Management Webinar, meticulously crafted to equip you and your team with essential strategies for understanding, addressing, and alleviating pain in your patients' lives. This webinar will delve into various topics, including the evolving role of pharmacists in pain management, the significance of timely intervention, and initiatives like Haleon's #ListenToPain campaign Pain is a universal experience, with nearly everyone encountering it at some point in their lives. Whether it's acute or chronic, pain can significantly diminish the quality of life and hinder daily activities. Understanding the multifaceted nature of pain is crucial in developing effective management strategies.

Patients suffering from chronic and episodic migraine attacks are set to benefit from a groundbreaking recommendation by the National Institute for Health and Care Excellence (NICE) regarding a new medication. The atogepant, a first-of-its-kind preventive drug for migraine, offers hope for those grappling with this debilitating condition and can be taken orally. Published as part of the final guidance draft, NICE has greenlit the atogepant, also known as Aquipta and manufactured by AbbVie, as an option for preventing both chronic and episodic migraines in adults. Specifically, this recommendation is for individuals who have experienced at least four migraine days per month and have failed to find relief with at least three previous preventive treatments. With approximately 4.5 million people in the UK affected by various forms of migraine, this new recommendation marks a significant advancement in migraine management as the condition significantly impacts patients' day-to-day activities as well as places a heavy burden on the NHS and the wider economy.

Eli Lilly's weight-loss medicine Mounjaro, also known as tirzepatide, will be available in the UK within weeks as a four-dose pre-filled injection pen. The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the drug to treat adults with type 2 diabetes and for weight management in obese patients. Branded as Mounjaro KwikPen, the injection is to be used together with a reduced-calorie diet and increased physical activity, the regulator said. "The public health importance of safe and effective treatments to help manage diabetes and obesity, which can have a significant impact on people's health, is clear. "This approval enables access to the approved Mounjaro pen in a more convenient presentation of a month's treatment, of one dose per week," said Julian Beach, MHRA Interim Executive Director, Healthcare Quality and Access.

With more than half of the UK population experiencing gum problems and many not believing their condition warrants treatment, there is a significant need for an oral care range that promotes good gum health and prevents future issues. Corsodyl is set to launch a new Gum Strength & Protect line, featuring two toothpastes and a daily mouthwash which are clinically proven to protect against gum problems. This range aims to meet the growing consumer demand for oral care solutions that help proactively manage gum health and prevent issues related to poor oral hygiene. The Corsodyl Gum Strength & Protect line is designed to strengthen the gum seal around teeth, offering long-lasting protection. The product is enriched with hyaluronic acid, a key building block for strong gums, and includes IPMP (Isopropyl Methylphenol) and zinc as antibacterial active ingredients.

With the UK General Election set for 4 July, pharmacy bodies are actively engaging with all political parties to secure support for the community pharmacy sector. They are pressing parties to address urgent issues such as pharmacy closures and medicine shortages. "The upcoming general election is a critical opportunity for us to strengthen supporters of community pharmacy in readiness for the new Parliament," said Janet Morrison, chief executive of Community Pharmacy England (CPE). She stressed the need for unity within the sector in advocating for community pharmacy and raising awareness of the issues with election candidates from all parties. As the general election approaches, CPE has called upon all political parties to support pharmacies by "introducing a long-term sustainable funding model and reviewing the medicines supply chain, including much-needed short-term relief measures."

"Barcodes are becoming obsolete, so we needed a unique selling point," comments Business Development Manager at Huxley Europe, Richard Wertheimer, celebrating the relaunch of its HuxQ10 capsules. Now boasting a rare triple certification, HuxQ10 capsules are Halal approved by Halal Trust, Kosher approval by Rabbi Adler, and certification as vegan. This milestone marks a significant step for the company, making HuxQ10 accessible to a wider audience. Coenzyme Q10, or Q10, is a naturally occurring vitamin-like substance in the body, playing a crucial role in mitochondrial biogenetics and ATP production, which is vital for cellular energy. It also acts as a powerful antioxidant, capable of regenerating alpha-tocopherol, the active form of vitamin E.

The latest NHS data showed that 487,432 individuals in England were diagnosed with dementia in June, the highest since the start of the pandemic. Although dementia diagnosis rates have reached 65 per cent, the NHS still aims to meet its target of diagnosing 66.7 per cent of the estimated total number of people living with a form of the disease. NHS stated that their staff across the country are actively assessing care home residents to identify more individuals who may have dementia. Dr. Jeremy Isaacs, National Clinical Director for Dementia at NHS England, praised the efforts of NHS staff in increasing diagnosis rates but acknowledged that more work is needed. "Getting a diagnosis of dementia is the first step in supporting people, with a wide range of NHS services able to help.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication of semaglutide (Wegovy), authorising its use to reduce the risk of serious heart problems and strokes in adults who are obese or overweight. Semaglutide, a GLP-1 receptor agonist, was previously approved for use in the treatment of obesity and weight management, to be used alongside diet, physical activity and behavioural support. The latest approval establishes it as the first weight loss drug to be prescribed to prevent cardiovascular events, such as cardiovascular death, non-fatal heart attack and non-fatal stroke, in people with established cardiovascular disease and a Body Mass Index (BMI) higher or equal to 27 kg/m2. Novo Nordisk, the manufacturer of Wegovy, received this authorisation on 23 July following compelling evidence from a recent post-approval clinical study involving over 17,600 participants. The study demonstrated that Wegovy, administered at a dose of 2.4 mg once weekly via subcutaneous injection for up to five years, significantly lowers the incidence of major adverse cardiovascular events (MACE) by 20 per cent compared to a placebo.

A corporate bootcamp has become a perfect option to bring employees together but also for those who often miss health program through a shortage of time.

If you are sick of doing likewise exhausting activities than London boot camp preparing is likely for you. The camp furnishes you with the chance to meet individuals and standardize while you work out.

Are you struggling to lose weight? The good news is, simple day to day activities can help you reduce weight and enhance your looks. Here are a few things you can consider to lose weight. Climb Stairs Climbing the stairs up and down is a good way to exercise and tone your body.

Acne, pimples, and zits make us look unappealing and we tend to rob ourselves from social activities. #pimples #acne #acnetreatment https://youtu.be/_Dhid4cVreQ

Arthrella is a rich combination of joint support phytochemicals. Arthrella combines the extracts of 4 herbs which offer support to the bones and the joints and help regulate healthy active joints and muscles. Arthrella helps in promoting normal structure and functioning of musculoskeletal system Social Media Site https://www.youtube.com/user/CharakPharma https://www.facebook.com/CharakPharma https://twitter.com/charak_pharma https://plus.google.com/+charakpharma https://www.linkedin.com/company/charak-pharma-pvt.-ltd. https://www.pinterest.com/OTCSupermarket/charak-pharma/ https://plus.google.com/u/0/communities/112690639266834894016 CONTACT US Charak Pharma (USA) inc 303-5th Avenue, Suite # 1007 New York, NY 10016 United States Website- http://www.charakusa.com/ Email : enquiry@charakusa.com info@charakusa.com 91 22 33016734 Google My Business Location- http://listings.findthecompany.com/l/474216049/Charak-Pharma-Usa-Inc-in-New-York-NY Buy Innoveda Arthrella Online - Shop, Cart & checkout Page Url Shop - http://www.charakusa.com/shop/ Add to Card - http://www.charakusa.com/cart/ Proceed to Checkout- http://www.charakusa.com/checkout/

Acujoint is a highly efficient formulation with natural bio actives used for joint pain treatment. It is made by patent pending PNS Technology for maintaining healthy joints.

Liposomal CBD Colorado Hemp Oil delivers a nanoemulsified oil that is 40% CBD. The nanoemulsified is formatted for ultimate bioavailability, delivering biologically active substances directly to lymphatic circulation and improving cellular delivery.

EHR technology increases performance in terms of meaningful use and helps to implement improvement activities efficiently. Patient portals, user-friendly websites, adopting technology are great ways to improve patients' outcomes. Thus, allowing patients the ease to enroll and get prescriptions is a huge step towards a progressive healthcare system

Medical billing process relies on efficient medical billing and coding services. It is an intricate activity that requires a lot of concentration and precision.  Medical billers and coder need to be professional and capable enough of handling multitasking.

Getting patient referrals is a sign of a physician's expertise and goodwill in the healthcare industry. How medical practitioners can increase the number of referrals and earn reimbursements and incentives in QPP MIPS

Survival in the healthcare industry is getting tough day by day. The cost factor to provide value-based healthcare services is doing well in patients' favor, but it's also been a burden for physicians. While MIPS reporting services, MIPS Quality Measures are the parameters to show progress in terms of interoperability, cost, quality, and improvement activities.

Getting patient referrals is a sign of a physician's expertise and goodwill in the healthcare industry. How medical practitioners can increase the number of referrals and earn reimbursements and incentives in QPP MIPS.

Learn about improvement activities (IA) reporting requirements for MIPS 2021 data submission. You can target 15 points for this category.